Literature DB >> 35253014

DEVELOPMENT OF A PORTABLE BLOOD POTASSIUM MONITORING DEVICE FOR DIALYSIS PATIENTS.

Parth Vora1, Miguel Inserni1, Alan Lai1, Maya M Lapinski1, Justin Wang1, Min Jae Kim1, Diane Lee1, Rebecca Yu1, Amir Manbachi1,2, Mohamed G Atta3.   

Abstract

Approximately 500,000 dialysis patients in America are at a high risk of hyperkalemia, a condition where blood potassium becomes elevated above normal levels. Hyperkalemia is extremely dangerous, as it can result in severe cardiac complications if untreated. Hyperkalemia may be silent or present vague symptoms until those complications develop, at which point patients require emergency medical care. However, if patients have the ability to measure their potassium levels at home, they could detect hyperkalemia before it reaches a dangerous stage, and seek preventative medical care to avoid severe complications. Therefore, we have designed a novel device allowing patients to measure their blood potassium levels at home. The workflow of our solution is as follows: (1) patients obtain a blood sample from a finger prick, (2) potassium concentration is measured with an ion specific electrode (ISE), and (3) the device displays their potassium levels and a recommended course of action based on their hyperkalemic risk. We validate our solution with three major tests. First, our portable ISE technology must accurately measure potassium concentration in blood samples. Second, appropriate lancet parameters (gauge and depth) to minimize hemolysis in capillary blood samples must be found to minimize falsely elevated readings. Third, device portability and ease of use must be evaluated using patient input, as these factors will affect patient compliance. We have validated the use of portable ISE technology to feasibly measure potassium, and we continue to collect data for our second and third tests.

Entities:  

Year:  2020        PMID: 35253014      PMCID: PMC8895231          DOI: 10.1115/dmd2020-9066

Source DB:  PubMed          Journal:  Des Med Devices Conf (2020)


  5 in total

Review 1.  Effectiveness of practices to reduce blood sample hemolysis in EDs: a laboratory medicine best practices systematic review and meta-analysis.

Authors:  Nicholas J Heyer; James H Derzon; Linda Winges; Colleen Shaw; Diana Mass; Susan R Snyder; Paul Epner; James H Nichols; Julie A Gayken; Dennis Ernst; Edward B Liebow
Journal:  Clin Biochem       Date:  2012-09       Impact factor: 3.281

Review 2.  Early chronic kidney disease: diagnosis, management and models of care.

Authors:  Olivier J Wouters; Donal J O'Donoghue; James Ritchie; Panos G Kanavos; Andrew S Narva
Journal:  Nat Rev Nephrol       Date:  2015-06-09       Impact factor: 28.314

3.  Serum Potassium and Short-term Clinical Outcomes Among Hemodialysis Patients: Impact of the Long Interdialytic Interval.

Authors:  Steven M Brunelli; Charles Du Mond; Nina Oestreicher; Viatcheslav Rakov; David M Spiegel
Journal:  Am J Kidney Dis       Date:  2017-01-19       Impact factor: 8.860

4.  Sudden death and associated factors in a historical cohort of chronic haemodialysis patients.

Authors:  Simonetta Genovesi; Maria G Valsecchi; Emanuela Rossi; Daniela Pogliani; Irene Acquistapace; Vincenzo De Cristofaro; Andrea Stella; Antonio Vincenti
Journal:  Nephrol Dial Transplant       Date:  2009-03-16       Impact factor: 5.992

5.  Missed Hemodialysis Treatments: International Variation, Predictors, and Outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Authors:  Issa Al Salmi; Maria Larkina; Mia Wang; Lalita Subramanian; Hal Morgenstern; Stefan H Jacobson; Raymond Hakim; Francesca Tentori; Rajiv Saran; Takashi Akiba; Natalia A Tomilina; Friedrich K Port; Bruce M Robinson; Ronald L Pisoni
Journal:  Am J Kidney Dis       Date:  2018-08-23       Impact factor: 8.860

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.